CLRB

NASDAQStock

Cellectar Biosciences, Inc.

$3.19-0.04 (-1.39%)

52-Week Range

$2.56

$13.85

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.33

Volume

46.3K

Avg Volume

58.3K

Performance

-1.82%

+0.94%

-37.04%

YTD

-6.92%

-68.03%

-93.14%

-99.45%

Price Chart

ETF Exposure

CLRB is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	2	$10	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	89	$388	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$1	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	50,770	$163K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	267	$1K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	23	$100	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	31,114	$100K	$84.10B	0.05%

About CLRB ETF Exposure

Cellectar Biosciences, Inc. (CLRB) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $3.19. Investors can gain exposure to CLRB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CLRB, sorted by portfolio weight.